Amalgamated Bank Eye Point Pharmaceuticals, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,256 shares of EYPT stock, worth $26,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,256
Previous 2,256
-0.0%
Holding current value
$26,372
Previous $21,000
47.62%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EYPT
# of Institutions
165Shares Held
66.4MCall Options Held
264KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$97.3 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$79.5 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$79.5 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$51.6 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$48.8 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $398M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...